Delivery Order SPE2DB22D2206-SPE2DB25FJE89
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Savella (milnacipran) 100 mg tablets in a 60-count quantity. This is a firm fixed-price, non-set-aside contract with a ceiling value of $3,669.15 and an ultimate completion date of July 29, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Savella 50 mg tablets, a medication used to treat fibromyalgia. The contract has a ceiling value of $2,733.67 and a completion date of June 18, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price valued at $3,885.10 and an ultimate completion date of March 13, 2025. The contract is for the supply of Savella 50 mg tablets, a medication used to treat fibromyalgia. The contract does not have a set-aside designation, indicating open competition....
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,457,817 units of the pharmaceutical product SAVELLA 50 MG TABLET 60S. The contract has a potential value of $1,039.63 and a completion date of January 29, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) with DLA that has a potential value of up to $999,999,999.00 and a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Savella 50 mg tablets, a prescription medication. The contract has a ceiling value of $2,330.10 and a period of performance through May 9, 2025. The contract is not set aside and is awarded as a firm-fixed-price delivery order. Amerisourcebergen Drug Corp holds a larger...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,309.08 firm fixed price delivery order is for the supply of Savella 50 mg tablets. The contract has an ultimate completion date of May 3, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA)...
- This is a $6,848.07 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SAVELLA 25 MG TABLET 60S, a medication, with a period of performance through March 12, 2025. This contract is not set aside for any specific business type. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, with an ID of SPE2DB22D1106|SPE2DB25FECK5, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SAVELLA 50 MG TABLET 60S, a pharmaceutical product, with a ceiling value of $8,904.95 and a completion date of March 11, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
- This federal contract award, valued at $4,205.05, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567557934 - SAVELLA 25 MG TABLET 60S, with a period of performance through March 11, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,019.82, is for the delivery of Savella 12.5 mg tablets to support military healthcare programs. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen, which serves as a primary vehicle for...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJE89Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Savella 100 mg tablets (60-count units) with a ceiling value of $4,750.50. This firm fixed-price delivery order, with an ultimate completion date of August 4, 2025, represents a non-set-aside competitive award and is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Savella (milnacipran) is a serotonin-norepinephrine reuptake inhibitor prescribed for fibromyalgia treatment, reflecting the Defense Logistics Agency's ongoing pharmaceutical procurement to support military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of brand-name and generic medications, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp's consistent performance in competitively awarded federal contracts and its significant IDC position demonstrate its capability as a critical vendor for federal medical supply needs across multiple therapeutic domains and customer bases including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.8k | 8/1/25 |